NCT02309008

A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects

A Randomized, Double-blind, Placebo-controlled Multiple Dosing Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream After Transdermal Administration in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Amorepacific Corporation · Industry
• Sex: Male
• Age: 19 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the safety/tolerability and pharmacokinetics of PAC-14028 cream after transdermal administration in healthy male volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	PAC-14028	Participants will receive PAC-14028 cream applied topically once a day for 9 days
OTHER	Vehicle	Participants will receive vehicle cream applied topically once a day for 9 days

Timeline

• Start date: 2014-11-01
• Primary completion: 2016-04-01
• First posted: 2014-12-05
• Last updated: 2016-04-22

Locations

1 site across 1 country: South Korea